|

Essen Amyloidosis Registry

RECRUITINGSponsored by University Hospital, Essen
Actively Recruiting
SponsorUniversity Hospital, Essen
Started2024-05-08
Est. completion2029-01-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06887283

Summary

The Essen Amyloidosis Registry (EAR) is a prospective, observational registry designed to collect comprehensive clinical data on patients diagnosed with systemic amyloidosis. The registry aims to improve the understanding of disease progression, diagnostic pathways, and treatment outcomes. The registry is hosted at the University Hospital Essen and follows patients longitudinally. Inclusion is open to all patients with suspected or confirmed amyloidosis who provide informed consent.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Suspected or confirmed amyloidosis (any)
* Written informed consent to participate in the study
* Age 18 years and above

Exclusion Criteria:

* Age \< 18 years
* Lack of written informed consent

Conditions4

Amyloidosis CardiacAmyloidosis; SystemicCancerHeart Disease

Browse More Trials

Cancer trialsHeart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.